Multiple Myeloma: Related News

On Our Blog

Pictured: Ross Levine
New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

December 9, 2013
Pictured: Sergio Giralt
Memorial Sloan Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012

Related Media Coverage

ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013